{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:49:48Z","timestamp":1773416988620,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ind J Clin Biochem"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12291-024-01237-5","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T14:03:42Z","timestamp":1716905022000},"page":"243-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational Analysis of Differentially Expressed Circulating MicroRNA and Identification of Key Genes in Prostate Cancer"],"prefix":"10.1007","volume":"41","author":[{"given":"Anveshika","family":"Manoj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-411X","authenticated-orcid":false,"given":"Mohammad Kaleem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"3","key":"1237_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA A Cancer J Clin"},{"issue":"2","key":"1237_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate Cancer. World J Oncol. 2019;10(2):63\u201389. https:\/\/doi.org\/10.14740\/wjon1191.","journal-title":"World J Oncol"},{"issue":"9","key":"1237_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/biomedicines9091247","volume":"9","author":"I Henr\u00edquez","year":"2021","unstructured":"Henr\u00edquez I, Roach M, Morgan TM, Bossi A, G\u00f3mez JA, Abuchaibe O, Counago F. Current and emerging therapies for metastatic castration-resistant prostate cancer (MCRPC). Biomedicines. 2021;9(9):1247. https:\/\/doi.org\/10.3390\/biomedicines9091247.","journal-title":"Biomedicines"},{"issue":"8","key":"1237_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrurol.2014.151","volume":"11","author":"RA Modh","year":"2014","unstructured":"Modh RA, Mulhall JP, Gilbert M. Sexual dysfunction after cystectomy and urinary diversion. Nat Rev Urol. 2014;11(8):445\u201353. https:\/\/doi.org\/10.1038\/nrurol.2014.151.","journal-title":"Nat Rev Urol"},{"issue":"13","key":"1237_CR5","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.3390\/ijms23137167","volume":"23","author":"PT Ho","year":"2022","unstructured":"Ho PT, Clark IM, Le LT. MicroRNA-based diagnosis and therapy. Int J Mol Sci. 2022;23(13):7167.","journal-title":"Int J Mol Sci"},{"key":"1237_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43650","author":"T Shegekar","year":"2023","unstructured":"Shegekar T, Vodithala S, Juganavar A. The emerging role of liquid biopsies in revolutionising cancer diagnosis and therapy. Cur\u0113us. 2023. https:\/\/doi.org\/10.7759\/cureus.43650.","journal-title":"Cur\u0113us"},{"issue":"8","key":"1237_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","volume":"8","author":"MA Cortez","year":"2011","unstructured":"Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids\u2014the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467\u201377. https:\/\/doi.org\/10.1038\/nrclinonc.2011.76.","journal-title":"Nat Rev Clin Oncol"},{"issue":"63","key":"1237_CR8","doi-asserted-by":"publisher","first-page":"107167","DOI":"10.18632\/oncotarget.22363","volume":"8","author":"T Kehl","year":"2017","unstructured":"Kehl T, Backes C, Kern F, Fehlmann T, Ludwig N, Meese E, Lenhof H-P, Keller A. About miRNAs, miRNA seeds, target genes and target pathways. Oncotarget. 2017;8(63):107167\u201375. https:\/\/doi.org\/10.18632\/oncotarget.22363.","journal-title":"Oncotarget"},{"issue":"3","key":"1237_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.prnil.2023.06.002","volume":"11","author":"A Manoj","year":"2023","unstructured":"Manoj A, Ahmad MK, Prasad G, Kumar D, Mahdi AA, Kumar M. Screening and validation of novel serum panel of microRNA in stratification of prostate cancer. Prostate Int. 2023;11(3):150\u20138. https:\/\/doi.org\/10.1016\/j.prnil.2023.06.002.","journal-title":"Prostate Int"},{"issue":"1","key":"1237_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/nar\/gkaa1161","volume":"49","author":"F Kern","year":"2021","unstructured":"Kern F, Krammes L, Danz K, Diener C, Kehl T, K\u00fcchler O, et al. Validation of human microRNA target pathways enables evaluation of target prediction tools. Nucleic Acids Res. 2021;49(1):127\u201344. https:\/\/doi.org\/10.1093\/nar\/gkaa1161.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1237_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/bfgp\/elw042","volume":"16","author":"V Shukla","year":"2017","unstructured":"Shukla V, Varghese VK, Kabekkodu SP, Mallya S, Satyamoorthy K. A compilation of Web-based research tools for miRNA analysis. Brief Funct Genom. 2017;16(5):249\u201373. https:\/\/doi.org\/10.1093\/bfgp\/elw042.","journal-title":"Brief Funct Genom"},{"issue":"3","key":"1237_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/genes5030671","volume":"5","author":"S Ekimler","year":"2014","unstructured":"Ekimler S, Sahin K. Computational methods for MicroRNA target prediction. Genes. 2014;5(3):671\u201383. https:\/\/doi.org\/10.3390\/genes5030671.","journal-title":"Genes"},{"key":"1237_CR13","doi-asserted-by":"publisher","first-page":"1066118","DOI":"10.3389\/fgene.2022.1066118","volume":"13","author":"T Shinawi","year":"2022","unstructured":"Shinawi T, Nasser KK, Moradi FA, Mujalli A, Albaqami WF, Almukadi HS, et al. A comparative mRNA-and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers. Front Genet. 2022;13:1066118. https:\/\/doi.org\/10.3389\/fgene.2022.1066118.","journal-title":"Front Genet"},{"issue":"6472","key":"1237_CR14","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, Bartel DP. The biochemical basis of microRNA targeting efficacy. Science. 2019;366(6472):1741. https:\/\/doi.org\/10.1126\/science.aav1741.","journal-title":"Science"},{"issue":"10","key":"1237_CR15","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS ONE. 2018;13(10):e0206239.","journal-title":"PLoS ONE"},{"issue":"D1","key":"1237_CR16","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"H Huang","year":"2021","unstructured":"Huang H, Lin Y-C-D, Cui S, Huang Y, Tang Y, Jiatong X, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA\u2013target interactions. Nucleic Acids Res. 2021;50(D1):D222\u201330. https:\/\/doi.org\/10.1093\/nar\/gkab1079.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"1237_CR17","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Ming Hao J, Qiu XJ, Baseler MW, Clifford Lane H, Imamichi T, Chang W. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021\u00a0update). Nucleic Acids Res. 2022;50(W1):W216\u201321. https:\/\/doi.org\/10.1093\/nar\/gkac194.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1237_CR18","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"J-H Li","year":"2013","unstructured":"Li J-H, Liu S, Zhou H, Liang-Hu Q, Yang J-H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013;42(D1):D92\u20137. https:\/\/doi.org\/10.1093\/nar\/gkt1248.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1237_CR19","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"issue":"20","key":"1237_CR20","doi-asserted-by":"publisher","first-page":"11088","DOI":"10.3390\/ijms222011088","volume":"22","author":"T Pungsrinont","year":"2021","unstructured":"Pungsrinont T, Kallenbach J, Baniahmad A. Role of PI3K-AKT-MTOR Pathway as a Pro-survival signaling and resistance-mediating mechanism to therapy of prostate cancer. Int J Mol Sci. 2021;22(20):11088. https:\/\/doi.org\/10.3390\/ijms222011088.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1237_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10534","volume":"22","author":"JW Shin","year":"2021","unstructured":"Shin JW, Kim SH, Yoon JY. PTEN downregulation induces apoptosis and cell cycle arrest in uterine cervical cancer cells. Exp Ther Med. 2021;22(4):1\u20137. https:\/\/doi.org\/10.3892\/etm.2021.10534.","journal-title":"Exp Ther Med"},{"key":"1237_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2017.11.017","volume":"50","author":"M Hornsveld","year":"2018","unstructured":"Hornsveld M, Dansen TB, Derksen PW, Burgering BMT. Re-evaluating the role of FOXOs in cancer. Semin Cancer Biol. 2018;50:90\u2013100. https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.017.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"1237_CR23","doi-asserted-by":"publisher","first-page":"e70987","DOI":"10.1371\/journal.pone.0070987","volume":"8","author":"X Li","year":"2013","unstructured":"Li X, Chen Y-T, Josson S, Mukhopadhyay NK, Kim J, Freeman MR, Huang W-C. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells. PLoS ONE. 2013;8(8):e70987. https:\/\/doi.org\/10.1371\/journal.pone.0070987.","journal-title":"PLoS ONE"},{"issue":"1-2","key":"1237_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11010-013-1576-z","volume":"377","author":"Q Fajun","year":"2013","unstructured":"Fajun Q, Cui X, Hong Y, Wang J, Yao Li L, Chen YL, Gao Y, Danfeng X, Wang Q. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol Cell Biochem. 2013;377(1\u20132):121\u201330. https:\/\/doi.org\/10.1007\/s11010-013-1576-z.","journal-title":"Mol Cell Biochem"},{"key":"1237_CR25","unstructured":"Ostadrahimi S, Abedi\u2010Valugerdi M, Hassan MM, Haddad G, Fayaz S, ParvizHamidi M, et al. MIR-1266\u20135P and MIR-185\u20135p promote cell apoptosis in human prostate cancer cell lines. Asian Pac J Cancer Prev. 2018;19(8):2305\u201311. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30141307."},{"key":"1237_CR26","doi-asserted-by":"crossref","unstructured":"Hao H, Chen H, Xie L, Liu H, Wang D. LNCRNA KCNQ1OT1 promotes proliferation, invasion and metastasis of prostate cancer by regulating MIR-211-5P\/CHI3L1 pathway. Onco Targets Ther. 2021 Mar 3;14:1659\u201371. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33688211\/","DOI":"10.2147\/OTT.S288785"},{"issue":"38","key":"1237_CR27","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1038\/onc.2009.192","volume":"28","author":"K-H Lee","year":"2009","unstructured":"Lee K-H, Chen Y-L, Yeh S-D, Hsiao M, Lin J-T, Goan Y-G, Lu P-J. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene. 2009;28(38):3360\u201370. https:\/\/doi.org\/10.1038\/onc.2009.192.","journal-title":"Oncogene"},{"issue":"9","key":"1237_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/cbr.2019.3123","volume":"35","author":"T Ma","year":"2020","unstructured":"Ma T, Chen H, Wang P, Yang N, Bao J. Downregulation of LNCRNA ZEB1-AS1 represses cell proliferation, migration, and invasion through mediating PI3K\/AKT\/MTOR signaling by MIR-342-3P\/CUL4B axis in prostate cancer. Cancer Biother Radiopharm. 2020;35(9):661\u201372. https:\/\/doi.org\/10.1089\/cbr.2019.3123.","journal-title":"Cancer Biother Radiopharm"},{"issue":"42","key":"1237_CR29","doi-asserted-by":"publisher","first-page":"72835","DOI":"10.18632\/oncotarget.20427","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang Y, Ji C, Guo S, Xin S, Zhao X, Zhang S, Liu G, Qiu X, Zhang Q, Guo H, Chen H. The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways. Oncotarget. 2017;8(42):72835\u201346. https:\/\/doi.org\/10.18632\/oncotarget.20427.","journal-title":"Oncotarget"},{"issue":"3","key":"1237_CR30","doi-asserted-by":"publisher","first-page":"e58929","DOI":"10.1371\/journal.pone.0058929","volume":"8","author":"T Chiyomaru","year":"2013","unstructured":"Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, et al. Genistein up-regulates tumor suppressor MicroRNA-574-3P in prostate cancer. PLoS ONE. 2013;8(3):e58929.","journal-title":"PLoS ONE"},{"key":"1237_CR31","doi-asserted-by":"crossref","unstructured":"Yan Y, Huang H (2019) Interplay among PI3KAKT, PTENFOXO and AR signaling in prostate cancer. Advances in experimental medicine and biology. Adv Exp Med Biol. 2019;1210:319\u201331. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31900915\/.","DOI":"10.1007\/978-3-030-32656-2_14"},{"key":"1237_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mcp.2017.07.002","volume":"36","author":"NM Ashraf","year":"2017","unstructured":"Ashraf NM, Imran K, Kastner DW, Ikram K, Mushtaq A, Hussain A, Zeeshan N. Potential involvement of mi-RNA 574-3p in progression of prostate cancer: a bioinformatic study. Mol Cell Probes. 2017;36:21\u20138. https:\/\/doi.org\/10.1016\/j.mcp.2017.07.002.","journal-title":"Mol Cell Probes"}],"container-title":["Indian Journal of Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12291-024-01237-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12291-024-01237-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12291-024-01237-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:54:30Z","timestamp":1773406470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12291-024-01237-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1237"],"URL":"https:\/\/doi.org\/10.1007\/s12291-024-01237-5","relation":{},"ISSN":["0970-1915","0974-0422"],"issn-type":[{"value":"0970-1915","type":"print"},{"value":"0974-0422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"14 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"No humans\/animals were used for studies that are the basis of this research.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}